Shi, XiarongMihaylova, Valia T.Kuruvilla, LeenaChen, FangViviano, StephenBaldassarre, MassimilianoSperandio, DavidMartinez, RubenYue, PengBates, Jamie G.Breckenridge, David G.Schlessinger, JosephTurk, Benjamin E.Calderwood, David A.2017-02-032017-02-032016-08-02Shi, X, Mihaylova, V T, Kuruvilla, L, Chen, F, Viviano, S, Baldassarre, M, Sperandio, D, Martinez, R, Yue, P, Bates, J G, Breckenridge, D G, Schlessinger, J, Turk, B E & Calderwood, D A 2016, 'Loss of TRIM33 causes resistance to BET bromodomain inhibitors through MYC- and TGF-β-dependent mechanisms', PNAS, vol. 113, no. 31, pp. E4558-4566. https://doi.org/10.1073/pnas.1608319113, https://doi.org/10.1073/pnas.1608319113/-/DCSupplemental0027-8424ORCID: /0000-0002-2498-4767/work/76976107http://hdl.handle.net/2164/8138ACKNOWLEDGMENTS. We thank Phillip B. Murray for help with the shRNA mapping pipeline and Francesc Lopez-Giraldez for help with RNAseq mapping software.93587222424586engSDG 3 - Good Health and Well-beingbromodomain inhibitorTRIM33JQ1drug resistanceTGF-βR MedicineSupplementary DataRLoss of TRIM33 causes resistance to BET bromodomain inhibitors through MYC- and TGF-β-dependent mechanismsJournal article10.1073/pnas.160831911311331